Decitabine-based therapy in relapsed and refractory patients with advanced solid tumors

来源 :第四届国际肿瘤表观遗传学大会 | 被引量 : 0次 | 上传用户：liongliong435

【摘要】

：

【作者】

：

Qian Mei Xiang Li Jing Nie Xiaohui Wang Mingzhou Guo Weidong Han

【机构】

：

Department of Bio-therapeutic, School of Life Sciences

【出处】

：

第四届国际肿瘤表观遗传学大会

【发表日期】

：

2014年8期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Solid tumor patients when progressed into advanced stages have poor prognosis even treated with intensive salvage regimens and are welcome subjects for clinical trial of new agents.Aberrant DNA methylation plays key driver role in tumor initiation and progression as well as the resistance to chemotherapy, and would be extremely useful in digging therapeutic strategies.

其他文献

HBx induces hypomethylation of distal intragenic CGIs required for active expression of developmenta

Epigenetic alterations caused by viral oncoproteins are strong initiation factors for cancer development, but their mechanisms are largely unknown.To identify the epigenetic effects of viral HBx that

会议

HBxHepatocellular carcinomaDNA methylationIntragenic CGIDNMT3L

Epigenome study of nasopharyngeal carcinoma revealed frequent epigenetic disruption of Wnt/b-catenin

NPC is a major tumor prevalent in South China and Southeast Asia, as the top cancer for males of 20-44 year-old.Previous genomic sequencing study showed only infrequent mutations in NPC, indicating a

会议

Increased Expression of miR-205, Regulated by Ionizing Radiation-Mediated Sp1 Activation, Promotes R

The micoRNA expression profile is dramatically changed in response to ionizing radiation (IR)and the dsyregulated micoRNA may regulate radiation sensitivity.Here we provide evidence that the miR-205,

会议

The Opportunity and Challenges of DNA Methylation Based Cancer Diagnostics: from the discovery drive

Cancer is a highly heterogeneous disease of the dysproliferating cells, suffering from extensive genomic and epigenomic defects.DNA methylation is the best characterized epigenetic mechanism, ensuring

会议

Establishment of a DNA Methylation Marker to Evaluate Cancer Cell Fraction in Gastric Cancer

Tumor samples are unavoidably contaminated by coexisting normal cells, but assessment of the cancer cell fraction is important to improve the accuracy of molecular studies.To estimate the cancer cell

会议

RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal ca

RASSF10 was frequently found to be methylated in different cancers.To understand the mechanism of RASSF10 in colorectal carcinogenesis, 8 colorectal cancer cell lines, 89 samples of primary colorectal

会议

Epigenetic silencing of DACH1 in triple negative breast cancer contributes to the tumorigenesis

BACKGROUND: Increasing evidence indicates that cell fate determination factor DACH1 functions as a tumor suppressor.Specifically, in estrogen receptor positive (luminal), elevated expression of DACH1

会议

Distinct roles of DNMT1-dependent and-independent methylation patterns in the genome of mouse ES cel

Background: DNA methylation patterns are critical for genome stability and gene transcription, and are initiated by de novo methylases DNMT3a/3b adding methyl groups to CG dinucleotides in the hypomet

会议

DNA methylation patternsgenome stabilitygene transcriptionde novo methyltrans

Aberrant DNA methylation of acute myeloid leukemia cases in a pedigree with MLL3 germline mutations

Unlike genetic aberrations, epigenetic alterations do not modify the DNA coding sequence, and can be reversed pharmacologically.Identifying a particular epigenetic alteration such as abnormal DNA meth

会议

acute myeloid leukemiaDNA methylationhypermethylationhypomethylation

NONCODE and NPInter, two databases providing comprehensive annotations of non-coding RNAs and relate

Non-coding RNAs (ncRNAs) have been implicated in diseases and identified to play important roles in various biological processes.NONCODE (http://www.bioinfo.org/noncode/) is an integrated knowledge da

会议

Decitabine-based therapy in relapsed and refractory patients with advanced solid tumors

与本文相关的学术论文